Novel thermally-stable COVID-19 vaccine capsule developed
Developers have announced that they are ready to manufacture and formulate an innovative novel coronavirus vaccine capsule.
List view / Grid view
Developers have announced that they are ready to manufacture and formulate an innovative novel coronavirus vaccine capsule.
The EMA has announced the results of its pharmacovigilance meeting for March, saying that it has started a review of medicines containing ifosfamide due to a higher risk of encephalopathy.
Researchers have created an innovative 3D printing carrier ink to drive the development of personalised biomaterials for cell and drug delivery.
The US FDA has granted Fast Track designation to Jardiance® for the treatment of chronic kidney disease.
The regulatory body has issued guidance based on a complaint that stated a precipitate formed in Aripiprazole 1mg/ml oral solution.
Novel particles could be incorporated into topical creams to treat dermatological conditions without systemic exposure to drugs.
US researchers have stated a newly approved HIV pre-exposure prophylaxis (PrEP) therapy does not have benefits that warrant its price tag and could deter generic competition.
Development of a new method to create chiral rotaxanes has allowed researchers to show they could be ideal environments for catalysts.
Using AAV-based technology to deliver mAbs in a Phase I trial, researchers report that participants successfully developed antibodies against HIV.
Researchers have identified a tiny protein in scorpion venom that rapidly accumulates in joint cartilage to deliver arthritis drugs in a pre-clinical study.
Tests conducted by an online pharmacy has revealed high levels of NMDA in the diabetes drug metformin, prompting the company to press for a recall.
A new vaccine formulation has been created by researchers, which uses a peelable film during drying to preserve the medicine.
The EMA has released an update on nitrosamines in drugs, saying that work is continuing to prevent and manage these impurities.
Researchers have developed a solid ‘cryogel’ vaccine that has been successful in combatting acute myeloid leukaemia in mice. How was this new formulation discovered and what potential does it have for cancer patients?
Ranitidine tablets have been recalled due to the possibility of the products containing unacceptable levels of NDMA.